One Patient. One Coordinator. One Connected Journey.
Discover recruiting clinical trials, emerging therapies, and medical research opportunities from leading hospitals and research institutions around the world. CrossCare AI helps you organize your information, understand the process, and connect with participating research sites.
CrossCare AI does not determine eligibility or provide medical advice. Eligibility decisions are made only by the research team conducting each study.
AI Clinical Trial Finder
Filter by condition, country, hospital, phase, and more.
Evaluating a next-generation CD19-directed CAR-T construct in adult patients with relapsed or refractory B-cell lymphoma who have received prior standard therapy.
Investigational autologous CRISPR-edited haematopoietic stem cell therapy for participants with severe sickle cell disease.
Long-term study of a dual incretin agonist assessing glycaemic control and cardiovascular outcomes in adults with T2D.
Molecularly-guided treatment assignment for adults with advanced solid tumours based on comprehensive genomic profiling.
Intra-articular autologous mesenchymal stem cell injection versus standard care for symptomatic knee osteoarthritis.
Confirmatory efficacy and safety study of a monoclonal antibody targeting brain amyloid in participants with early symptomatic Alzheimer's disease.
PD-1 and LAG-3 dual checkpoint inhibition versus PD-1 monotherapy in previously untreated metastatic melanoma.
Prospective study of a caregiver-mediated digital therapeutic on social communication outcomes in children with autism spectrum condition.
Long-term motor and quality-of-life outcomes of adaptive DBS programming in advanced Parkinson's disease.
AI Research Match
Upload records for the CrossCare AI team to organize alongside your case.
Medical records, laboratory results, imaging, or pathology reports. Files stay private to you and your assigned coordinator.
Organizational summary — not a determination of eligibility.
AI-generated summaries are provided for organizational purposes only and do not determine eligibility. Final eligibility is assessed by the clinical research team.
Research Categories
Browse active research across specialties and therapeutic areas.
Oncology
1,248 active studies
Diabetes
412 active studies
Cardiology
638 active studies
Neurology
524 active studies
Rare Diseases
187 active studies
Sickle Cell Disease
63 active studies
Stem Cell Research
219 active studies
Gene Therapy
174 active studies
Immunotherapy
296 active studies
Regenerative Medicine
138 active studies
Alzheimer's Disease
211 active studies
Parkinson's Disease
142 active studies
Autism
89 active studies
Women's Health
267 active studies
Children's Health
194 active studies
Mental Health
318 active studies
Infectious Diseases
405 active studies
Precision Medicine
231 active studies
Research Centers
Hospitals, universities, research institutes, and medical centers.
AI Eligibility Preparation
A preparation aid — never a diagnosis or an eligibility decision.
Your age appears to fall within the published study range.
Your condition appears related to the study.
Recent laboratory results may be required.
Additional imaging may be requested.
Your eligibility can only be confirmed after formal screening by the research investigators.
CrossCare AI helps you prepare thoughtful questions. Only the study's research investigators may determine eligibility.
Understanding Clinical Research
Clear, calm explanations of the research process and your rights.
Research studies with human volunteers that evaluate medical, surgical, or behavioural interventions under strict scientific and ethical oversight.
Phase I explores safety and dosing, Phase II examines efficacy, Phase III confirms benefit in larger populations, and Phase IV monitors long-term outcomes.
A voluntary, ongoing conversation between you and the research team. You review the purpose, procedures, risks, and benefits before deciding to participate.
Access to investigational therapies, close medical monitoring, and contributing to knowledge that may help future patients.
Unknown side effects, additional visits, or interventions that may not benefit you personally. The research team will discuss risks in detail.
You may withdraw at any time, ask questions, request updates, and expect confidentiality — regardless of the study's stage.
Independent boards and regulators review study data continuously. Serious concerns can pause or modify a study to protect participants.
Learn about eligibility, costs, travel, follow-up expectations, and how coordinators can help you organize your documents and communication.
Every step is optional — CrossCare AI supports you, without ever standing in for the research team.
Discover Study
Upload Records
AI Organizes Documents
Coordinator Review
Contact Research Site
Research Team Screening
Eligibility Decision
Participation (if accepted)
Follow-up
Latest Research & Medical Innovation
Curated updates from institutions and public research programs.
Research Dashboard
Save trials, follow conditions, and track your coordination in one place.
9
Research opportunities
recruiting worldwide
0
Saved trials
in your watchlist
0
Expressed interest
awaiting response
0
Research centers contacted
across your network
0
Screening appointments
no scheduled visits
0
Coordinator messages
all clear
0/0
Document status
records reviewed
0
Followed conditions
get new-study alerts
Healthcare Professional Portal
Participating hospitals, universities, and research institutes can publish studies, manage inquiries, and coordinate securely with patients and CrossCare AI care teams.
Request research portal accessCompliance & Transparency
The future of medicine
Whether you're interested in established treatments or innovative clinical research, CrossCare AI helps you discover opportunities and coordinate your next steps.